These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 19236217)

  • 1. Ultrasound contrast agents: balancing safety versus efficacy.
    Main ML; Goldman JH; Grayburn PA
    Expert Opin Drug Saf; 2009 Jan; 8(1):49-56. PubMed ID: 19236217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety With Echocardiographic Contrast Agents.
    Muskula PR; Main ML
    Circ Cardiovasc Imaging; 2017 Apr; 10(4):. PubMed ID: 28377467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute mortality in hospitalized patients undergoing echocardiography with and without an ultrasound contrast agent (multicenter registry results in 4,300,966 consecutive patients).
    Main ML; Ryan AC; Davis TE; Albano MP; Kusnetzky LL; Hibberd M
    Am J Cardiol; 2008 Dec; 102(12):1742-6. PubMed ID: 19064035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A retrospective comparison of mortality in critically ill hospitalized patients undergoing echocardiography with and without an ultrasound contrast agent.
    Exuzides A; Main ML; Colby C; Grayburn PA; Feinstein SB; Goldman JH
    JACC Cardiovasc Imaging; 2010 Jun; 3(6):578-85. PubMed ID: 20541713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The safety of deFinity and Optison for ultrasound image enhancement: a retrospective analysis of 78,383 administered contrast doses.
    Wei K; Mulvagh SL; Carson L; Davidoff R; Gabriel R; Grimm RA; Wilson S; Fane L; Herzog CA; Zoghbi WA; Taylor R; Farrar M; Chaudhry FA; Porter TR; Irani W; Lang RM
    J Am Soc Echocardiogr; 2008 Nov; 21(11):1202-6. PubMed ID: 18848430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute mortality in hospitalized patients undergoing echocardiography with and without an ultrasound contrast agent: results in 18,671 consecutive studies.
    Kusnetzky LL; Khalid A; Khumri TM; Moe TG; Jones PG; Main ML
    J Am Coll Cardiol; 2008 Apr; 51(17):1704-6. PubMed ID: 18436124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety profile of ultrasound enhancing agents in echocardiography.
    Kumar S; Purtell C; Peterson A; Gibbons P; Khan AM; Heitner SB
    Echocardiography; 2019 Jun; 36(6):1041-1044. PubMed ID: 31038768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Administration of perflutren contrast agents during transthoracic echocardiography is not associated with a significant increase in acute mortality risk.
    Goldberg YH; Ginelli P; Siegel R; Ostfeld RJ; Schaefer M; Spevack DM
    Cardiology; 2012; 122(2):119-25. PubMed ID: 22813648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ultrasound contrast agent safety: from anecdote to evidence.
    Main ML
    JACC Cardiovasc Imaging; 2009 Sep; 2(9):1057-9. PubMed ID: 19761982
    [No Abstract]   [Full Text] [Related]  

  • 10. CaRES (Contrast Echocardiography Registry for Safety Surveillance): a prospective multicenter study to evaluate the safety of the ultrasound contrast agent definity in clinical practice.
    Weiss RJ; Ahmad M; Villanueva F; Schmitz S; Bhat G; Hibberd MG; Main ML;
    J Am Soc Echocardiogr; 2012 Jul; 25(7):790-5. PubMed ID: 22560734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of myocardial contrast echocardiography on vascular permeability: comparison of three different contrast agents.
    Li P; Armstrong WF; Miller DL
    Ultrasound Med Biol; 2004 Jan; 30(1):83-91. PubMed ID: 14962612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thinking outside the "box"-the ultrasound contrast controversy.
    Main ML; Goldman JH; Grayburn PA
    J Am Coll Cardiol; 2007 Dec; 50(25):2434-7. PubMed ID: 18154971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics and Echogenicity of Clinical Ultrasound Contrast Agents: An In Vitro and In Vivo Comparison Study.
    Hyvelin JM; Gaud E; Costa M; Helbert A; Bussat P; Bettinger T; Frinking P
    J Ultrasound Med; 2017 May; 36(5):941-953. PubMed ID: 28240842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Update on the safety and efficacy of commercial ultrasound contrast agents in cardiac applications.
    Appis AW; Tracy MJ; Feinstein SB
    Echo Res Pract; 2015 Jun; 2(2):R55-62. PubMed ID: 26693339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety of echocardiographic contrast in hospitalized patients with pulmonary hypertension: a multi-center study.
    Wever-Pinzon O; Suma V; Ahuja A; Romero J; Sareen N; Henry SA; De Benedetti Zunino M; Chaudhry FF; Suryadevara RS; Sherrid MV; Chaudhry FA
    Eur Heart J Cardiovasc Imaging; 2012 Oct; 13(10):857-62. PubMed ID: 22427401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An observational study of the occurrence of serious adverse reactions among patients who receive optison in routine medical practice.
    Wei K; Shah S; Jaber WA; DeMaria A
    J Am Soc Echocardiogr; 2014 Sep; 27(9):1006-10. PubMed ID: 24930121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of adverse events associated with use of perflutren contrast agents for echocardiography.
    Herzog CA
    JAMA; 2008 May; 299(17):2023-5. PubMed ID: 18460662
    [No Abstract]   [Full Text] [Related]  

  • 18. Safety of Perflutren Ultrasound Contrast Agents: A Disproportionality Analysis of the US FAERS Database.
    Hauben M; Hung EY; Hanretta KC; Bangalore S; Snow V
    Drug Saf; 2015 Nov; 38(11):1127-39. PubMed ID: 26242615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perflutren-based echocardiographic contrast in patients with right-to-left intracardiac shunts.
    Kalra A; Shroff GR; Erlien D; Gilbertson DT; Herzog CA
    JACC Cardiovasc Imaging; 2014 Feb; 7(2):206-7. PubMed ID: 24524748
    [No Abstract]   [Full Text] [Related]  

  • 20. Sudden death after intravenous administration of a perflutren contrast agent: a case of pseudocomplication?
    Mahjoub H; Roméo P; Leung TK; Burelle D; Cartier R; Basmadjian AJ
    J Am Soc Echocardiogr; 2009 Jun; 22(6):753.e5-8. PubMed ID: 19269782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.